Citadel Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
CCA
KF
AWM
KAS
ASN
Citadel Advisors's BTAL Position: Q4 2025 in Review
Citadel Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 33,821 shares — an estimated $538K sold.
Citadel Advisors first reported a position in BTAL in Q2 2016 and held it in 13 quarters. The position peaked at $8.28M in Q3 2020. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.
- Citadel Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 33,821 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $538K.
- Citadel Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2016 and held it in 13 quarters.
- Citadel Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $8.28M in Q3 2020.
- 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.